The FDA has approved Datroway® (datopotamab deruxtecan-dlnk) for adult patients with unresectable or metastatic HR-positive, ...

The FDA has approved a novel combination therapy using Lumakras® (sotorasib) and Vectibix® (panitumumab) for adults with KRAS ...

Oncolytics Biotech received approval from Germany\u2019s Paul-Ehrlich-Institute to advance Cohort 5 of the GOBLET study, ...

Ariceum Therapeutics announced that the FDA has cleared its investigational new drug application to commence a Phase I/II ...

The Internet of Medical Things (IoMT) is set to radically change the quality of care and outcomes for millions of patients, ...